🇺🇸 FDA
Patent

US 9713635

Materials and methods for producing improved lentiviral vector particles

granted A61KA61K2039/5256A61K2039/5258

Quick answer

US patent 9713635 (Materials and methods for producing improved lentiviral vector particles) held by IMMUNE DESIGN CORP. expires Mon Jul 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
IMMUNE DESIGN CORP.
Grant date
Tue Jul 25 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
32
CPC classes
A61K, A61K2039/5256, A61K2039/5258, A61K39/0011, A61K39/001106